{
  "meta": {
    "id": "test50",
    "title": "National_Health_Programs-National_TB_Elimination_Program__NTEP_",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "How many weight band categories are present in the Daily Drug Regimen (DDR) for the treatment of tuberculosis in adults?",
      "options": [
        {
          "label": "A",
          "text": "Five",
          "correct": true
        },
        {
          "label": "B",
          "text": "Six",
          "correct": false
        },
        {
          "label": "C",
          "text": "Three",
          "correct": false
        },
        {
          "label": "D",
          "text": "Four",
          "correct": false
        }
      ],
      "correct_answer": "A. Five",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:576px\">\n<tbody>\n<tr>\n<td rowspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Weight category (kg)</strong></p>\n</td>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Number of tablets (FDCs)</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Intensive phase- 4 FDC (HRZE)- 75/100/400/275</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Continuation phase- 3 FDC (HRE)- 75/150/275</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>25-34</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>35-49</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>60-64</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>65-75</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>5</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>5</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>>75*</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>6</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>6</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Note: Patients >75 kg may receive five tablets per day if they do not tolerate the revised dose.</p>\n<ul>\n<li>Total doses taken in the <span class=\"customMeta\" data-dictid=\"901bf573f216927771905f0abedca2\">Intensive</span> phase (IP) is 56 doses.</li>\n<li>Total doses taken in the Continuation phase (CP) is 112 doses.</li>\n</ul>\n</td>\n</tr>\n<tr>\n</tr>\n</tbody>\n</table>\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n<tbody>\n<tr>\n<td rowspan=\"4\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Weight category (kg)</strong></p>\n</td>\n<td colspan=\"4\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Number of tablets (dispersibe FDCs)</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Intensive phase</strong></p>\n</td>\n<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Continuation phase</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>HRZ</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>E</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>HR</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>E</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>50/75/150</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>100</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>50/75</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>100</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4-7</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>8-11</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>12-15</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>16-24</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>25-29</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3 + 1A*</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3 + 1A*</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>30-39</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2 + 2A*</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2 + 2A*</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2</p>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/MTB1968N0J4z8aCvT1P21747246961.mp3",
      "video": "",
      "uid": "51f7aad8"
    },
    {
      "text": "According to the NTEP guidelines, what population size does each Tuberculosis Unit (TU) cover?",
      "options": [
        {
          "label": "A",
          "text": "1 per 50,000 in rural/urban areas and 1 per 25,000 in hilly/tribal areas",
          "correct": false
        },
        {
          "label": "B",
          "text": "1 per 100,000 in rural/urban areas and 1 per 50,000 in hilly/tribal areas",
          "correct": false
        },
        {
          "label": "C",
          "text": "1 per 200,000 in rural/urban areas and 1 per 100,000 in hilly/tribal areas",
          "correct": true
        },
        {
          "label": "D",
          "text": "1 per 300,000 in rural/urban areas and 1 per 150,000 in hilly/tribal areas",
          "correct": false
        }
      ],
      "correct_answer": "C. 1 per 200,000 in rural/urban areas and 1 per 100,000 in hilly/tribal areas",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/content/Xhtk2887qRBFZzRmf5sm1734267734.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/cWBRvnDUKZ37KUDeDpEj1747246517.mp3",
      "video": "",
      "uid": "82cd5632"
    },
    {
      "text": "Which initiative in India focuses on supporting District Drug Resistant TB Centres (DDR -TC) in management of drug-resistant tuberculosis (TB)?",
      "options": [
        {
          "label": "A",
          "text": "Indian TB Genomic Surveillance Consortium",
          "correct": false
        },
        {
          "label": "B",
          "text": "DT3 Centers",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dare2eraD TB (2022)",
          "correct": false
        },
        {
          "label": "D",
          "text": "TRACE-TB Project",
          "correct": false
        }
      ],
      "correct_answer": "B. DT3 Centers",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/fn2xxYTkR65PN8K1YL5F1743280132.mp3",
      "video": "",
      "uid": "82ce87b4"
    },
    {
      "text": "When is World Tuberculosis (TB) Day observed, and what is the theme for 2024?",
      "options": [
        {
          "label": "A",
          "text": "March 24; \"Invest to End TB. Save Lives.\"",
          "correct": false
        },
        {
          "label": "B",
          "text": "March 24; \"Yes! We Can End TB.\"",
          "correct": true
        },
        {
          "label": "C",
          "text": "April 24; \"The Clock is Ticking.\"",
          "correct": false
        },
        {
          "label": "D",
          "text": "April 24; \"Unite to End TB.\"",
          "correct": false
        }
      ],
      "correct_answer": "B. March 24; \"Yes! We Can End TB.\"",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/1P44KGcvjmiNpNxpNWnG1743280259.mp3",
      "video": "",
      "uid": "9a5e8a5e"
    },
    {
      "text": "Which technology-based initiative has been implemented by the Indian government to track and manage tuberculosis (TB) cases?",
      "options": [
        {
          "label": "A",
          "text": "Swasthya Sathi",
          "correct": false
        },
        {
          "label": "B",
          "text": "eVIN",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nikshay",
          "correct": true
        },
        {
          "label": "D",
          "text": "Aarogya Setu",
          "correct": false
        }
      ],
      "correct_answer": "C. Nikshay",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/content/0i4SjOYtsuB6hbDOB0SL1725457951.png",
        "https://image.prepladder.com/content/LsGlWexPRkDDSyGUkwnz1725457967.png",
        "https://image.prepladder.com/content/JAwZwcBswyvvv1phbP1m1725447608.png",
        "https://image.prepladder.com/content/GuaWAEOf5TrASoJp17fW1725457983.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/RC3EfSpClF1HqAgxAyGy1743280578.mp3",
      "video": "",
      "uid": "bcebf1e1"
    },
    {
      "text": "What is the monthly financial incentive provided under the Nikshay Poshan Yojana for TB patients to support their nutritional needs?",
      "options": [
        {
          "label": "A",
          "text": "Rs 300",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rs 500",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rs 750",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rs 1000",
          "correct": false
        }
      ],
      "correct_answer": "B. Rs 500",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/FyGkg0eBCZ5udNm1bIKA1743280752.mp3",
      "video": "",
      "uid": "6c717d78"
    },
    {
      "text": "You diagnose a 35 year old man with tuberculosis. Further questioning his social history reveals that he lives with his elderly parents and wife in a seemingly small apartment. Which of the following would you recommend as prophylactic treatment for his family members?",
      "options": [
        {
          "label": "A",
          "text": "Isoniazid (600mg OD) for 6 months",
          "correct": false
        },
        {
          "label": "B",
          "text": "Shorter TPT (TB Preventive Therapy) - Rifapentine + Isoniazid weekly for 3 months",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pyrizinamide (800mg OD) for 3 months.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rifampicin (1500mg OD) for 9 months.",
          "correct": false
        }
      ],
      "correct_answer": "B. Shorter TPT (TB Preventive Therapy) - Rifapentine + Isoniazid weekly for 3 months",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/content/JDfBgjz1fn3oKlvurGzP1734267125.png"
      ],
      "explanation": "<table>\n<thead>\n<tr>\n<th><strong>Regimen</strong></th>\n<th><strong>Drugs Used</strong></th>\n<th><strong>Duration</strong></th>\n<th><strong>Target Groups</strong></th>\n<th><strong>Notes</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><strong>3HP</strong></td>\n<td>Isoniazid + Rifapentine (weekly)</td>\n<td>3 months</td>\n<td>Adults and children >2 years, PLHIV, household contacts</td>\n<td>WHO-recommended; shorter duration improves adherence</td>\n</tr>\n<tr>\n<td><strong>6H</strong></td>\n<td>Isoniazid daily</td>\n<td>6 months</td>\n<td>All age groups, including children and PLHIV</td>\n<td>Traditional regimen; effective but lower <span class=\"customMeta\" data-dictid=\"5f8b7d103016927771806be7e4190b\">adherence</span> due to long duration</td>\n</tr>\n<tr>\n<td><strong>3HR</strong></td>\n<td>Isoniazid + Rifampicin daily</td>\n<td>3 months</td>\n<td>Children <15 years, PLHIV, household contacts</td>\n<td>WHO-recommended; safe for children</td>\n</tr>\n<tr>\n<td><strong>4R</strong></td>\n<td>Rifampicin daily</td>\n<td>4 months</td>\n<td>Individuals intolerant to INH, or where INH resistance is suspected</td>\n<td>Alternative <span class=\"customMeta\" data-dictid=\"988bd8e7c71692777197b9f1d5d5ca\">regimen</span> when INH is contraindicated</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/VgT2JkOB20jhJRVlAHHf1747247946.mp3",
      "video": "",
      "uid": "129e6078"
    },
    {
      "text": "A 25 year old woman, who is 18 weeks pregnant, is diagnosed with MDR-TB. She comes to you for advice on how to proceed with her pregnancy and treatment. What is the most appropriate management plan for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Start the Shorter oral Bedaquiline regimen immediately and continue the pregnancy.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Advise Medical Termination of Pregnancy (MTP) and if done, start the Shorter oral Bedaquiline regimen.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Start the Longer oral Bedaquiline regimen immediately and continue the pregnancy.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Continue the pregnancy without initiating any TB treatment until the second trimester.",
          "correct": false
        }
      ],
      "correct_answer": "B. Advise Medical Termination of Pregnancy (MTP) and if done, start the Shorter oral Bedaquiline regimen.",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/content/ziLK59wxxFfPjP5zcluw1734266925.png",
        "https://image.prepladder.com/content/8BsEUSC4NL6uKeEYl6KT1734266990.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/FKMeXcKoNow2hlob0jCW1747247111.mp3",
      "video": "",
      "uid": "dfe5dab9"
    },
    {
      "text": "Which of the following is false regarding the BPaL regimen used in the treatment of tuberculosis?",
      "options": [
        {
          "label": "A",
          "text": "It was first studied clinically in the Nix-TB trial conducted by WHO",
          "correct": false
        },
        {
          "label": "B",
          "text": "It can be used in patients with XDR-TB",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is used to treat MDR-TB patients who are unresponsive to treatment",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is used only in Rifampicin-resistant TB",
          "correct": true
        }
      ],
      "correct_answer": "D. It is used only in Rifampicin-resistant TB",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/rwudQZiGIwues1Grjh2K1747247368.mp3",
      "video": "",
      "uid": "d66e3959"
    },
    {
      "text": "A 30 year old female came with complaints of evening rise of temperature, night sweats, cough and blood in sputum for the past 5 weeks. The doctor suspects TB and orders Sputum AFB, CBNAAT, and chest X-ray for the patient. All of the tests come out positive confirming her diagnosis of TB. The CBNAAT shows she is resistant to rifampicin but sensitive to isoniazid on first-line LPA. Which of the following would be the most appropriate treatment regimen for her?",
      "options": [
        {
          "label": "A",
          "text": "18 months:BDQC\u2082L\u2082 (Bdq-Bedaquiline, C-Cycloserine, C-Clofazimine, L-Linezolid, L-Levofloxacin).",
          "correct": false
        },
        {
          "label": "B",
          "text": "4-6 months: CHOOBZEEt (Z-Pyrazinamide, E-Ethambutol, E-Ethionamide, C-Clofazimine, H-high dose Isoniazid, O-Levofloxacin, B-bedaquiline).\u00b7 5 months: COZE (Z-Pyrazinamide, E-Ethambutol, O-Levofloxacin, C-Clofazimine).",
          "correct": true
        },
        {
          "label": "C",
          "text": "2 months : HRZE (H-Isoniazide, R- Rifampicin, Z-Pyrazinamide, E-Ethambutol) 4 months: HRE (H-Isoniazide, R- Rifampicin, E-Ethambutol)",
          "correct": false
        },
        {
          "label": "D",
          "text": "6 months: ZERO (Z-Pyrazinamide, E-Ethambutol, R-Rifampicin, O-Levofloxacin).",
          "correct": false
        }
      ],
      "correct_answer": "B. 4-6 months: CHOOBZEEt (Z-Pyrazinamide, E-Ethambutol, E-Ethionamide, C-Clofazimine, H-high dose Isoniazid, O-Levofloxacin, B-bedaquiline).\u00b7 5 months: COZE (Z-Pyrazinamide, E-Ethambutol, O-Levofloxacin, C-Clofazimine).",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>4-6 months of CHOBZEEt </strong></p>\n<p><strong>(Intensive phase)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Upto 5 months of COZE (continuation phase)</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Z - </strong>Pyrazinamide</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Z - </strong>Pyrazinamide</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>E - </strong>Ethambutol</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>E - </strong>Ethambutol</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>E -</strong> Ethionamide</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>O - </strong>Levofloxacin</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>C - </strong>Clofazimine</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>C - </strong>Clofazimine</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>H - </strong>high dose Isoniazid</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>O - </strong>Levofloxacin</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>B - </strong>bedaquiline</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\u00a0</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/MubLxCeoXFWyMpULc2h21747247519.mp3",
      "video": "",
      "uid": "daa59b51"
    },
    {
      "text": "Which of the following statements is true regarding global initiative to control TB ?",
      "options": [
        {
          "label": "A",
          "text": "To eliminate TB by 2050 under the End TB initiative.",
          "correct": false
        },
        {
          "label": "B",
          "text": "To reduce mortality of TB by 80% under Sustainable Development Goals",
          "correct": false
        },
        {
          "label": "C",
          "text": "To reduce mortality & incidence of TB by 90% under the Stop TB initiative",
          "correct": false
        },
        {
          "label": "D",
          "text": "To reduce incidence of TB by 80% under Sustainable Development Goals",
          "correct": true
        }
      ],
      "correct_answer": "D. To reduce incidence of TB by 80% under Sustainable Development Goals",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/content/oMBDyY1kOrFaIojsrBjw1734265492.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/5QC1aVvGPWuBuzISSKnd1743279221.mp3",
      "video": "",
      "uid": "afde383a"
    },
    {
      "text": "A 45 year old woman presents to a Community Health Center (CHC) with a persistent cough, fever, and night sweats for the past three weeks. She has significant weight loss and a known history of contact with a TB patient. The clinician suspects TB and aims to confirm the diagnosis. According to NTEP guidelines, which of the following diagnostic modalities is not typically used for the initial diagnosis of TB?",
      "options": [
        {
          "label": "A",
          "text": "Sputum smear microscopy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chest X-ray",
          "correct": false
        },
        {
          "label": "C",
          "text": "F/S Line Probe Assay",
          "correct": true
        },
        {
          "label": "D",
          "text": "TruNAAT/CBNAAT",
          "correct": false
        }
      ],
      "correct_answer": "C. F/S Line Probe Assay",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:648px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Diagnostic Modality</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Usage</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Sputum <span class=\"customMeta\" data-dictid=\"6777533153169277719804fcbbf2d1\">Smear</span> Microscopy</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Microscopic examination of <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">sputum</span> samples to detect <span class=\"customMeta\" data-dictid=\"440f2b916316927771808b8ad44a64\">acid-fast</span> <span class=\"customMeta\" data-dictid=\"fe0005a48b1692777182143f69e1d5\">bacilli</span> (AFB).</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Used for initial screening and diagnosis, especially in resource-limited settings.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Chest X-ray</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Imaging done to identify abnormalities suggestive of TB.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Used to support diagnosis when clinical suspicion is high; not <span class=\"customMeta\" data-dictid=\"32b854324a1692777185c6c79fdc99\">definitive</span> for TB diagnosis.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>TruNAAT/CBNAAT</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Molecular tests that detect Mycobacterial DNA and <span class=\"customMeta\" data-dictid=\"6cd890fc7416927771978562618db8\">rifampicin</span> resistance.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Recommended for initial diagnosis due to high sensitivity and specificity; rapid results.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Line <span class=\"customMeta\" data-dictid=\"175eb86b5f16927771964d5ced6bf3\">Probe</span> <span class=\"customMeta\" data-dictid=\"fc026ff6d81692777182835f6de6df\">Assay</span> (LPA)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Molecular test to detect specific genetic mutations associated with <span class=\"customMeta\" data-dictid=\"36f0ccd0621692777186c1c3cecf48\">drug resistance</span> (e.g., rifampicin, isoniazid).</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Used for detecting <span class=\"customMeta\" data-dictid=\"36f0ccd0621692777186c1c3cecf48\">drug resistance</span> in confirmed TB cases, not for initial diagnosis.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Tuberculin Skin Test (TST)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>A skin test to measure <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> to <span class=\"customMeta\" data-dictid=\"6a367ebd0c169277719091155a5b0f\">injected</span> <span class=\"customMeta\" data-dictid=\"0fe92012341692777201bab3db39b1\">tuberculin</span> protein.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Primarily used for screening <span class=\"customMeta\" data-dictid=\"cec2565ecd1692777191eed58869b2\">latent</span> TB infection; not specific for active TB diagnosis.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Interferon-Gamma Release Assays (IGRAs)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Blood <span class=\"customMeta\" data-dictid=\"0ac01cc0c31692777185cae5f28175\">cytokine</span> analysis test that measures <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> to TB antigens.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Used for detecting <span class=\"customMeta\" data-dictid=\"cec2565ecd1692777191eed58869b2\">latent</span> TB infection</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Sputum Culture</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Growing <span class=\"customMeta\" data-dictid=\"46f768d2e41692777193d69cbc7eec\">Mycobacteria</span> from <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">sputum</span> samples to confirm TB and test for drug susceptibility.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Gold standard for TB diagnosis; takes several weeks to obtain results.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Drug <span class=\"customMeta\" data-dictid=\"6ced8252211692777199ab0cc3f2bb\">Susceptibility</span> Testing (DST)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Testing TB bacteria from patient samples to determine resistance to TB drugs.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Used to guide treatment by identifying <span class=\"customMeta\" data-dictid=\"d4c88fcae71692777186aa1c32423a\">drug-resistant</span> strains in confirmed TB cases.</p>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/brpzbayb1LbiWNGIUzO01747246295.mp3",
      "video": "",
      "uid": "ca143bb3"
    },
    {
      "text": "A 50 year old man diagnosed with TB has undergone drug susceptibility testing (DST). The results show that he is resistant to both isoniazid and rifampicin but susceptible to all fluoroquinolones and second-line injectable drugs. According to the classification based on drug resistance in the NTEP guidelines, how should this patient's case be categorized?",
      "options": [
        {
          "label": "A",
          "text": "Monoresistant TB",
          "correct": false
        },
        {
          "label": "B",
          "text": "Polydrug-resistant TB",
          "correct": false
        },
        {
          "label": "C",
          "text": "Multidrug-resistant TB (MDR-TB)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Extensively drug-resistant TB (XDR-TB)",
          "correct": false
        }
      ],
      "correct_answer": "C. Multidrug-resistant TB (MDR-TB)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:634px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Category</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Drug sensitive TB</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Patients are sensitive to 4 TB drugs: R,H,Z,E (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol).</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Mono-resistant (MR) (Option A)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Resistant to one 1st line anti-TB drug only.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>H-Mono-resistant (H-MR)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Resistant to <span class=\"customMeta\" data-dictid=\"5d8c24b3cb16927771909a5195d7f8\">Isoniazid</span> (H) only.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Rifampicin resistant (RR)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Resistant to <span class=\"customMeta\" data-dictid=\"6cd890fc7416927771978562618db8\">Rifampicin</span> (R) only.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Multi drug resistant (MDR) (Option C)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Resistant to both <span class=\"customMeta\" data-dictid=\"6cd890fc7416927771978562618db8\">Rifampicin</span> (R) & <span class=\"customMeta\" data-dictid=\"5d8c24b3cb16927771909a5195d7f8\">Isoniazid</span> (H).</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Poly-Drug resistant (PDR) (Option B)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Resistant to 2 drugs other than <span class=\"customMeta\" data-dictid=\"6cd890fc7416927771978562618db8\">Rifampicin</span> (R) & <span class=\"customMeta\" data-dictid=\"5d8c24b3cb16927771909a5195d7f8\">Isoniazid</span> (H).</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Pre-Xtensive resistant (pre-XDR)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Any <span class=\"customMeta\" data-dictid=\"3c0021ebec1692777192f766374e40\">MDR</span> patient (H+R) resistant to any fluoroquinolone.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Extensive resistant (XDR) (Option D)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Any <span class=\"customMeta\" data-dictid=\"3c0021ebec1692777192f766374e40\">MDR</span> patient (H+R) resistant to any <span class=\"customMeta\" data-dictid=\"f4975edd0b1692777203b54cf45c2d\">fluoroquinolone</span> and Group 4 drugs (Bedaquiline, Linezolid, Levo/Moxifloxacin).</p>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/7HvsAeeiaDlUMN25kV5n1747246111.mp3",
      "video": "",
      "uid": "669fc922"
    },
    {
      "text": "A 40 year old woman has been diagnosed with TB. Her medical records indicate she completed a full course of TB treatment and was declared cured two years ago. However, she is now presenting with symptoms of TB again and has a positive sputum test. According to the classification based on the history of previous TB treatment under the NTEP, how should this patient's case be categorized?",
      "options": [
        {
          "label": "A",
          "text": "New case",
          "correct": false
        },
        {
          "label": "B",
          "text": "Treatment after failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Treatment after loss to follow-up",
          "correct": false
        },
        {
          "label": "D",
          "text": "Recurrent TB case",
          "correct": true
        }
      ],
      "correct_answer": "D. Recurrent TB case",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Category</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>New case (Option A)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Newly diagnosed case and has never taken TB treatment before/taken treatment for <1 month duration.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Previously treated case</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Taken TB treatment earlier for >1 month.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Recurrent TB case</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>TB patient declared cured or treatment complete, presents again as a microbiologically confirmed TB case.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Treatment after failure (Option B)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>TB patient who had been treated for TB & presents as a failure at the most recent course of treatment or is positive even at 5 months of treatment.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Treatment after loss to follow up (Option C)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>A TB patient who received treatment for >1 month & registered as loss to follow up, is presenting again as a microbiologically positive TB case.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Other previously treated patients</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Earlier treatment is not known or not documented.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Transferred in</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Treatment starts at one TB unit, then the patient is transferred to another TB unit.</p>\n</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/QTyXoAt9sDwLjX4I5GYV1747164066.mp3",
      "video": "",
      "uid": "c6cf2a6c"
    },
    {
      "text": "A 35 year old man visits the clinic with a persistent cough and fever lasting for more than 2 weeks. He also reports experiencing night sweats and significant weight loss over the past month. Sputum smear tests or radiological tests are not yet done. According to the new terminologies in NTEP, how should this patient's case be categorized?",
      "options": [
        {
          "label": "A",
          "text": "Clinically diagnosed TB case",
          "correct": false
        },
        {
          "label": "B",
          "text": "TB suspect",
          "correct": false
        },
        {
          "label": "C",
          "text": "Sputum negative TB case",
          "correct": false
        },
        {
          "label": "D",
          "text": "Presumptive TB case",
          "correct": true
        }
      ],
      "correct_answer": "D. Presumptive TB case",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Category</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Description</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p style=\"text-align: center;\"><strong>Criteria/Features</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Presumptive TB Case</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li><strong>Used in place of TB suspect</strong>.</li>\n<li>Individuals showing symptoms suggestive of TB but not yet confirmed.</li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Cough, Fever, <span class=\"customMeta\" data-dictid=\"a696a8e86016927771939c84736fbb\">Night sweats</span> +- Weight loss > 2 weeks</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Clinically Diagnosed TB Case</strong></p>\n<p><strong>(Option A)</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Sputum negative but with high clinical suspicion of TB.</li>\n<li><strong>Used in place of <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">Sputum</span> negative TB case. (Option C)</strong></li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Persistent symptoms despite negative <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">sputum</span> smear</li>\n<li>High clinical suspicion based on symptoms, radiological and <span class=\"customMeta\" data-dictid=\"1e9c8202241692777189dbac6cc062\">histological</span> features</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Bacteriologically Confirmed TB Case</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Biological <span class=\"customMeta\" data-dictid=\"c02ad9ae0f1692777198d76afc93c4\">specimen</span> is positive for <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">sputum</span> AFB and/or CBNAAT.</li>\n<li><strong>Used in place of <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">Sputum</span> positive TB case.</strong></li>\n</ul>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<ul>\n<li>Positive <span class=\"customMeta\" data-dictid=\"5353537f861692777199e48431cd88\">sputum</span> <span class=\"customMeta\" data-dictid=\"6777533153169277719804fcbbf2d1\">smear</span> for AFB</li>\n<li>Positive CBNAAT test confirming the presence of TB bacteria</li>\n</ul>\n</td>\n</tr>\n</tbody>\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/ZrMmr2tlpQ4RTA6ihgbT1747245726.mp3",
      "video": "",
      "uid": "beb06930"
    },
    {
      "text": "Select the correct option for a treatment protocol according to NTEP which does not have a separate Intensive and Continuation phase. a. Drug-sensitive TB b. H mono/poly drug-resistant TB c. Shorter oral bedaquiline regimen d. Longer M/XDR-TB regimen",
      "options": [
        {
          "label": "A",
          "text": "b, c and d",
          "correct": false
        },
        {
          "label": "B",
          "text": "b and d",
          "correct": true
        },
        {
          "label": "C",
          "text": "a, c and d",
          "correct": false
        },
        {
          "label": "D",
          "text": "b and c",
          "correct": false
        }
      ],
      "correct_answer": "B. b and d",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<table cellspacing=\"0\" style=\"border-collapse:collapse; width:624px\">\n<tbody>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Regimen Class</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Intensive Phase</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Continuation Phase</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Notes</strong></p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Drug-sensitive TB</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>2 months: H+R+Z+E</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4 months: H+R+E</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">-</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>H mono/poly <span class=\"customMeta\" data-dictid=\"d4c88fcae71692777186aa1c32423a\">drug-resistant</span> TB</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>6 months: Lfx+R+E, Z</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>No separate phase</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">-</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Shorter oral <span class=\"customMeta\" data-dictid=\"d0a85225e8169277718252304cfc4b\">bedaquiline</span> <span class=\"customMeta\" data-dictid=\"988bd8e7c71692777197b9f1d5d5ca\">regimen</span> (Shorter MDR-TB</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>4-6 months: Bdq+Lfx+Cfz+Z+E+H(high dose)+Eto.</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>5 months: Lfx+Cfz+Z+E</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>Bdq to be given for 6 months.</p>\n<p>H to be given in high doses.</p>\n</td>\n</tr>\n<tr>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>Longer M/XDR-TB regimen</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p>18-20 months: Lfx+Bdq+Lzd+Cfz+Cs</p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n<p><strong>No separate phase</strong></p>\n</td>\n<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">-</td>\n</tr>\n</tbody>\n\n\n\n<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/UCgLgRO3bRryW4Yvah9k1747245552.mp3",
      "video": "",
      "uid": "88b58247"
    },
    {
      "text": "Match the following: a. Active case Detection i) Hospital reports are used for case detection b. Intensified case finding ii) ASHA workers receive incentive of Rs. 500 for finding a presumptive case c. Community based screening iii) Initiates screening of TB symptoms d. Passive case detection iv) ASHA workers collect details of risk factors of TB and diabetes.",
      "options": [
        {
          "label": "A",
          "text": "a-ii, b-iii, c-iv, d-i",
          "correct": true
        },
        {
          "label": "B",
          "text": "a-iii, b-ii, c-i, d-iv",
          "correct": false
        },
        {
          "label": "C",
          "text": "a-iv, b-iii, c-ii, d-i",
          "correct": false
        },
        {
          "label": "D",
          "text": "a-i, b-iii, c-ii, d-iv",
          "correct": false
        }
      ],
      "correct_answer": "A. a-ii, b-iii, c-iv, d-i",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/Ae5H9uwNs240GJOOdQaI1747248071.mp3",
      "video": "",
      "uid": "b03604b9"
    },
    {
      "text": "Which of the following is the main component of the JEET strategy to control TB ?",
      "options": [
        {
          "label": "A",
          "text": "To increase the notification rates of TB by private practitioners.",
          "correct": true
        },
        {
          "label": "B",
          "text": "To open various testing centers for TB",
          "correct": false
        },
        {
          "label": "C",
          "text": "Latest pharmaceutical innovation for early detection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Improved infrastructure for better isolation facilities to control TB",
          "correct": false
        }
      ],
      "correct_answer": "A. To increase the notification rates of TB by private practitioners.",
      "question_images": [],
      "explanation_images": [
        "https://image.prepladder.com/content/RhOi9oVrcPGcmq25TRgo1734265957.png"
      ],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/98AG4aBIEwNfUqOpcIaC1743279881.mp3",
      "video": "",
      "uid": "b8cc924a"
    },
    {
      "text": "Which of the following is not the strategy of NTEP ?",
      "options": [
        {
          "label": "A",
          "text": "CB-NAAT done for Anyone with cough > 2 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "TRUENAT gives result of rifampicin resistance within 1 hour",
          "correct": false
        },
        {
          "label": "C",
          "text": "Shorter & Longer oral MDR/XDR regimens are introduced.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Aim is to Prevent, Detect and Treat",
          "correct": true
        }
      ],
      "correct_answer": "D. Aim is to Prevent, Detect and Treat",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/SvuRdLMjqTl2iSjAPnao1743279723.mp3",
      "video": "",
      "uid": "b757a3d8"
    },
    {
      "text": "Which of the following statements is true?",
      "options": [
        {
          "label": "A",
          "text": "To eliminate TB by 2025 under National Tuberculosis Elimination Programme",
          "correct": true
        },
        {
          "label": "B",
          "text": "Eliminate malaria throughout the entire country by 2050 under National Framework for Malaria Elimination in India",
          "correct": false
        },
        {
          "label": "C",
          "text": "To achieve zero new infection and AIDS-related deaths by 2035",
          "correct": false
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "A. To eliminate TB by 2025 under National Tuberculosis Elimination Programme",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p style='font-size: 10px; color: #808080; font-style: italic;'></p>",
      "bot": "@dams_new_robot",
      "audio": "https://image.prepladder.com/content/CSZ5wIIpjh0Bm5icjeMX1743279524.mp3",
      "video": "",
      "uid": "685ef88d"
    }
  ]
}